by Jordana Choucair | Jul 14, 2022 | Life Sciences
The Food and Drug Administration (FDA) authorized Novavax Inc.’s two-dose COVID-19 shot for emergency use for adults, putting Americans one step away from a fourth vaccine option. Novavax, whose COVID-19 vaccine is the first in the U.S. that uses traditional...
by Jordana Choucair | Jul 13, 2022 | Life Sciences
The Food and Drug Administration (FDA) is expected to authorize Novavax’s coronavirus vaccine for emergency use as early as today. The authorization would likely permit the two-dose vaccine to be given to adults as a primary immunization series, limiting its use in...
by Jordana Choucair | Jul 13, 2022 | Life Sciences
Merck filed a lawsuit against the Biden administration to avoid potential fines for cutting off 340B contract pharmacies from getting discounted products. In 2021, Merck, along with nearly 20 drugmakers, cut off sales of 340B-discounted drugs to contract pharmacies,...
by Jordana Choucair | Jul 12, 2022 | Life Sciences
The federal government announced that it plans to secure an initial 3.2 million doses of Novavax’s COVID-19 vaccine. If the Food and Drug Administration (FDA) grants the vaccine an Emergency Use Authorization (EUA), the government will make the vaccine available for...
by Jordana Choucair | Jul 11, 2022 | Life Sciences
HRA Pharma asked the Food and Drug Administration (FDA) to authorize its birth control pill for over-the-counter sales, the first such application in the U.S., which comes just weeks after the fall of Roe v. Wade. The drugmaker’s chief strategic and innovations...
by Jordana Choucair | Jul 8, 2022 | Life Sciences
Beginning next year, pharmaceutical companies must repay Medicare for any injectable and infused drugs that come in single-dose vials and go unused, in a bid to cut down on the billions of dollars that are wasted every year on discarded drugs. Drug companies that...
Recent Comments